REDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for its second quarter of fiscal 2026, ended September 30, 2025. Leveraging best-in-class technology, strategic execution, and automation-driven operational efficiencies to mai ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Hey, good afternoon everyone. I'm Charles Payne. This is making money.So, the long awaited rotation move is starting to gain some momentum, right. And of course, you see what's happening. They're pressuring the mega cap stocks.Uh, and it show shareholders, listen, are up huge in these names, really big. Uh, but we're also seeing the pressure on the broader market as well, which in a way is ironic because it will mask in the the improving breath will be masked when you see that, okay, the indicy is down. Now ...

Here to discuss it all is Renaissance Macros head of technical research Jeff Jeff Degraph. Jeff, uh, great to have you on. I mean, I guess we've seen these rotations before.Sometimes they're painless, sometimes they're more disruptive. Is anything getting knocked off course today in this action. >> I don't think of off course, Mike.Um, you know, I think actually what's interesting is some of these real real highf flyers, particularly in the Russell 3000, the quantum names and, you know, some of the uranium ...

This post originally appeared in the First Trade newsletter. You can sign up for Business Insider's daily markets newsletter here. Good morning and welcome to First Trade. The US penny is officially dead. Are you glad? Or are you a heartbroken coin-collecting penny obsessive? Let me know at firsttrade@businessinsider.com. Rundown Hungry for an 'everything rally'? Then watch this five-part checklist from a chief strategist at Wells Fargo. Famed short-seller Andrew Left is back. He told BI why he's be ...

Core Insights - The performance divergence between the Dow Jones Industrial Average and Nasdaq Composite indicates the existence of two distinct markets in the U.S.: one driven by artificial intelligence and another encompassing traditional sectors [1][4]. Group 1: Dow Jones Industrial Average - The Dow Jones Industrial Average reached a record high, closing above 48,000 for the first time, marking its second consecutive record [1]. - The index, consisting of 30 blue-chip companies, is primarily composed of established firms in sectors like banking, healthcare, and industrials, reflecting the "old economy" [2]. - Key contributors to the Dow's rise included stocks from Goldman Sachs, Eli Lilly, and Caterpillar [2]. Group 2: Nasdaq Composite - The Nasdaq Composite, which is heavily weighted towards technology firms, experienced a decline due to falling shares of companies like Oracle and Palantir, despite a 9% increase in Advanced Micro Devices' stock [4]. - The Nasdaq's market capitalization weighting means that larger tech companies have a more significant impact on its performance compared to the price-weighted Dow [3]. Group 3: Market Sentiment - There is no immediate concern regarding overexuberance in AI investments, but a desire exists among investors for a convergence of the two market paths for a more stable investment environment [5].

The Dow Jones Industrial Average (^DJI) experienced a significant advance today, Wednesday, November 12, 2025, closing up 326.86 (0.6820%) points at 48254.82. This positive movement was largely driven by optimism surrounding the imminent end of the 43-day U.S. government shutdown, with the House of Representatives poised to vote on legislation to fund the government until January 30. This key policy development provided a strong tailwind for investor sentiment, signaling a potential resolution to economic u ...

Group 1 - The article promotes a weekly newsletter focused on stocks in the biotech, pharma, and healthcare industries, highlighting key trends and catalysts that influence market valuations [1] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group, which caters to both novice and experienced investors [1] - The investing group provides insights such as buy and sell ratings, product sales forecasts, integrated financial statements, discounted cash flow analysis, and market-specific analyses for major pharmaceutical companies [1]

Core Insights - Wall Street has experienced a significant rally in 2023, primarily driven by advancements in artificial intelligence (AI) technology, particularly generative and agentic AI, which have transformed the information technology sector globally [1] Group 1: Non-Tech Stocks with Growth Potential - Several non-tech companies have emerged as strong investment opportunities alongside tech giants, with a favorable Zacks Rank indicating potential for fruitful investments by 2026 [2] - The selected non-tech stocks include Southern Copper Corp. (SCCO), HCA Healthcare Inc. (HCA), General Motors Co. (GM), Morgan Stanley (MS), and Capital One Financial Corp. (COF), all holding a Zacks Rank 1 (Strong Buy) [2] Group 2: Southern Copper Corp. (SCCO) - Southern Copper has the largest copper reserves in the industry and operates in investment-grade countries like Mexico and Peru, positioning it for enhanced performance through low-cost production and growth investments [5][6] - The company has a capital investment program exceeding $15 billion for this decade, with approximately $10.3 billion allocated to Peru, the second-largest copper producer [6] - SCCO's expected revenue and earnings growth rates for the next year are 1.5% and 12.1%, respectively, with a 14.4% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [8] Group 3: HCA Healthcare Inc. (HCA) - HCA Healthcare's revenues have increased by 7.2% year over year in the first nine months of 2025, driven by growth in admissions and inpatient surgeries, with projected revenues of $75-$76.5 billion for 2025 [11] - The company has engaged in multiple buyouts to expand its network and increase patient volumes, alongside a significant share repurchase of $7.5 billion and dividend payments of $517 million in the same period [12] - HCA's expected revenue and earnings growth rates for the next year are 4.3% and 8.4%, respectively, with a 5% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [13] Group 4: General Motors Co. (GM) - General Motors holds a 17% market share as the top-selling U.S. automaker, with strong demand for its brands and a 10% year-over-year sales increase in China [14] - The company's software and services division has generated $2 billion in revenue year to date, supported by 11 million OnStar subscribers, and it maintains strong liquidity of $35.7 billion [15] - GM's expected revenue and earnings growth rates for the next year are -0.7% and 7.9%, respectively, with a 0.6% improvement in the Zacks Consensus Estimate for next year's earnings over the last seven days [16] Group 5: Morgan Stanley (MS) - Morgan Stanley's focus on wealth and asset management, along with strategic acquisitions like EquityZen, is expected to enhance its top line, with projected revenue and investment banking fee increases of 11.7% and 12.8% in 2025 [17] - Despite challenges in trading revenue growth due to market volatility, the company maintains a solid balance sheet with efficient capital distributions [18] - MS's expected revenue and earnings growth rates for the next year are 4.1% and 5.8%, respectively, with a 0.1% improvement in the Zacks Consensus Estimate for next year's earnings over the last seven days [18] Group 6: Capital One Financial Corp. (COF) - Capital One's third-quarter 2025 results benefited from higher revenues, particularly from the Discover Financial acquisition, reshaping the credit card landscape [19] - Strong consumer loan demand is anticipated to support COF's net interest income, with solid credit card and online banking operations contributing to revenue growth [20] - COF's expected revenue and earnings growth rates for the next year are 18% and 6.2%, respectively, with a 2.5% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [20]

Let's bring in Kevin Green, senior markets correspondent right away to help set up the action today. Uh, all right, KG. Uh, let's get people started.So, what do you think is going to set the tone today. I mean, I feel like yes, we've made some progress. It seems like the needle is continuing to move forward on the government shutdown, but what sets the tone today. >> Yeah, I mean, the government shutdown seems like it's really kind of priced in at the moment.There's a little bit of a kink when it comes to t ...